Yann Mazabraud
CIK: 0001774702
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
RHYTHM PHARMACEUTICALS, INC.
Discretionary Trading P&L
Holdings
Transaction History (23 total)
- Aug 12, 2026RYTM
RHYTHM PHARMACEUTICALS, INC.
Sale(S)Direct1K shares at avg. $112.86$113K - Aug 12, 2026RYTM
RHYTHM PHARMACEUTICALS, INC.
Exercise(M)Direct46.6K shares at avg. $6.80$317K - Aug 12, 2026RYTM
RHYTHM PHARMACEUTICALS, INC.
Sale(S)Direct2.3K shares at avg. $111.80$257K - Aug 12, 2026RYTM
RHYTHM PHARMACEUTICALS, INC.
Sale(S)Direct3.6K shares at avg. $114.70$413K - Aug 12, 2026RYTM
RHYTHM PHARMACEUTICALS, INC.
Sale(S)Direct17.3K shares at avg. $117.47$2.0M - Aug 12, 2026RYTM
RHYTHM PHARMACEUTICALS, INC.
Sale(S)Direct18.2K shares at avg. $116.49$2.1M - Aug 12, 2026RYTM
RHYTHM PHARMACEUTICALS, INC.
Sale(S)Direct14.6K shares at avg. $115.43$1.7M - Apr 1, 2026RYTM
RHYTHM PHARMACEUTICALS, INC.
Exercise(M)Direct12.9K shares- - Mar 2, 2026RYTM
RHYTHM PHARMACEUTICALS, INC.
Award(A)DirectStock Options (Right to Buy)
35K shares- - Feb 14, 2026RYTM
RHYTHM PHARMACEUTICALS, INC.
Exercise(M)Direct10K shares- - Feb 11, 2026RYTM
RHYTHM PHARMACEUTICALS, INC.
Award(A)DirectRestricted Stock Units
23.4K shares- - Feb 1, 2026RYTM
RHYTHM PHARMACEUTICALS, INC.
Exercise(M)Direct5.5K shares- - Apr 29, 2025RYTM
RHYTHM PHARMACEUTICALS, INC.
Sale(S)Direct6.7K shares at avg. $65.08$439K - Apr 15, 2025RYTM
RHYTHM PHARMACEUTICALS, INC.
Exercise(M)Direct11.4K shares- - Apr 14, 2025RYTM
RHYTHM PHARMACEUTICALS, INC.
Exercise(M)Direct10.4K shares- - Apr 8, 2025RYTM
RHYTHM PHARMACEUTICALS, INC.
Sale(S)Direct9.3K shares at avg. $61.54$573K - Apr 8, 2025RYTM
RHYTHM PHARMACEUTICALS, INC.
Sale(S)Direct8.4K shares at avg. $60.37$509K - Mar 14, 2025RYTM
RHYTHM PHARMACEUTICALS, INC.
Sale(S)Direct55.8K shares at avg. $51.72$2.9M - Mar 14, 2025RYTM
RHYTHM PHARMACEUTICALS, INC.
Exercise(M)Direct75K shares at avg. $22.28$1.7M - Mar 14, 2025RYTM
RHYTHM PHARMACEUTICALS, INC.
Sale(S)Direct19.2K shares at avg. $50.79$975K - Feb 16, 2025RYTM
RHYTHM PHARMACEUTICALS, INC.
Exercise(M)Direct5.5K shares- - Feb 14, 2025RYTM
RHYTHM PHARMACEUTICALS, INC.
Award(A)DirectStock Options (Right to Buy)
60K shares- - Feb 14, 2025RYTM
RHYTHM PHARMACEUTICALS, INC.
Award(A)DirectRestricted Stock Units
40K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 12, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | Sale(S) | 1,000 | $112.86 | $112,856 | Direct |
| Aug 12, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | Exercise(M) | 46,625 | $6.80 | $317,050 | Direct |
| Aug 12, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | Sale(S) | 2,300 | $111.80 | $257,138 | Direct |
| Aug 12, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | Sale(S) | 3,605 | $114.70 | $413,477 | Direct |
| Aug 12, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | Sale(S) | 17,319 | $117.47 | $2,034,439 | Direct |
| Aug 12, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | Sale(S) | 18,208 | $116.49 | $2,121,125 | Direct |
| Aug 12, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | Sale(S) | 14,568 | $115.43 | $1,681,541 | Direct |
| Apr 1, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | Exercise(M) | 12,875 | - | $0 | Direct |
| Mar 2, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | Award(A) Stock Options (Right to Buy) | 35,000 | - | - | Direct |
| Feb 14, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | Exercise(M) | 10,000 | - | $0 | Direct |
| Feb 11, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | Award(A) Restricted Stock Units | 23,350 | - | - | Direct |
| Feb 1, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | Exercise(M) | 5,500 | - | $0 | Direct |
| Apr 29, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | Sale(S) | 6,745 | $65.08 | $438,946 | Direct |
| Apr 15, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | Exercise(M) | 11,405 | - | - | Direct |
| Apr 14, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | Exercise(M) | 10,375 | - | - | Direct |
| Apr 8, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | Sale(S) | 9,312 | $61.54 | $573,062 | Direct |
| Apr 8, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | Sale(S) | 8,438 | $60.37 | $509,435 | Direct |
| Mar 14, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | Sale(S) | 55,803 | $51.72 | $2,886,226 | Direct |
| Mar 14, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | Exercise(M) | 75,000 | $22.28 | $1,671,000 | Direct |
| Mar 14, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | Sale(S) | 19,197 | $50.79 | $975,046 | Direct |
| Feb 16, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | Exercise(M) | 5,500 | - | - | Direct |
| Feb 14, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | Award(A) Stock Options (Right to Buy) | 60,000 | - | - | Direct |
| Feb 14, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | Award(A) Restricted Stock Units | 40,000 | - | - | Direct |
1-23 of 23 transactions
About Mazabraud Yann
Mazabraud Yann (SEC CIK 0001774702) files insider reports with the SEC as EVP, Head of International of RHYTHM PHARMACEUTICALS, INC. (RYTM).
Signal8 holds 11 ownership filings by Mazabraud Yann, all Form 4s, filed between Feb 19, 2025 and Aug 14, 2026. Those filings report 23 transactions, from Feb 14, 2025 to Aug 12, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Mazabraud Yann's filings is in BOSTON, MA.
Recent filings by Mazabraud Yann
- Aug 12, 2026: Open-market sale of RYTM shares (Form 4, code S).
- Aug 12, 2026: Option exercise of RYTM shares (Form 4, code M).
- Aug 12, 2026: Open-market sales of RYTM shares (5 lines, Form 4, code S).
- Apr 1, 2026: Option exercise of RYTM shares (Form 4, code M).
- Mar 2, 2026: Grant or award of RYTM derivative securities (Form 4, code A).
Other insiders filing for RHYTHM PHARMACEUTICALS, INC. (RYTM)
- Meeker David P, President and CEO
- Smith Hunter C, Chief Financial Officer
- Joshi Manher, Chief Medical Officer
- Shulman Joseph, Chief Technical Officer
- Garfield Alastair, Chief Scientific Officer
- Lee Jennifer Kayden, EVP, Head of North America